Biotrance Exim Private Limited
About Biotrance Exim Private Limited
Data last updated:
Biotrance Exim Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the research and development sector. It was incorporated on 11 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC217363. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Teena Mukherjee and Bireshwar Mukherjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 195 Ground Floor East Of Kailash, New Delhi, Delhi, India – 110065.
The company is associated with 1 brand: Biotrance.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Biotrance Exim Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address195 Ground Floor East Of Kailash, New Delhi, Delhi, India – 110065
- IndustryResearch & Development, Research & Development
To see the full contact details of Biotrance Exim Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Biotrance Exim operates one associated brand: Biotrance. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers proteomics services and products for Indian life sciences research and drug discovery. | biotrance.com |
Financials of Biotrance Exim Private Limited
FY 2025 filings availableBiotrance Exim Private Limited reported revenue of ₹6,667 (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 29%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biotrance Exim Private Limited, buy the company report.
Board of directors of Biotrance Exim Private Limited
Biotrance Exim has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Teena Mukherjee | Director | 11 Apr 2011 | 15 Years 6 Months | Current |
| Bireshwar Mukherjee | Director | 11 Apr 2011 | 15 Years 6 Months | Current |
Auditor
Biotrance Exim Private Limited is audited by ANIL MAHABIR AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANIL MAHABIR AND ASSOCIATES | FY 2017 | 026082N |
Shareholding
The shareholding of Biotrance Exim Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Biotrance Exim Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biotrance Exim Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biotrance Exim Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biotrance Exim has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Biotrance Exim Private Limited, buy the company report.
Recent activity
Biotrance Exim Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Bireshwar Mukherjee was appointed as Director on 11 Apr 2011.
Frequently asked questions
Biotrance Exim is an active private limited company based in New Delhi, Delhi, India. The company works in the research and development industry. It was incorporated on 11 April 2011 (15+ years old) and is registered under CIN U24232DL2011PTC217363.
Biotrance Exim has 2 current directors:
- Teena Mukherjee - Director
- Bireshwar Mukherjee - Director
The latest financial statements of Biotrance Exim on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Biotrance Exim has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Biotrance Exim is U24232DL2011PTC217363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biotrance Exim was incorporated on 11 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Bireshwar Mukherjee was appointed as Director on 11 Apr 2011. Teena Mukherjee was appointed as Director on 11 Apr 2011.
The registered office of Biotrance Exim is at 195 Ground Floor East Of Kailash, New Delhi, Delhi, India – 110065.
Biotrance Exim operates in the research and development industry.
The compliance status of Biotrance Exim is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
